• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Authors » Andrea Applegate

Andrea Applegate

Articles

ARTICLES

BioWorld MedTech’s Neurology Extra for Feb. 19, 2021

Feb. 19, 2021
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Deep brain stimulation prevents epileptic seizures in mouse model; Researchers discover promising biomarkers to diagnose mild TBI; New information on how antidepressants affect the brain uncovered.
Read More

BioWorld MedTech’s Neurology Extra for Feb. 12, 2021

Feb. 12, 2021
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Understanding ‘brain fog’ in people with COVID-19; AD diagnostics could become more accessible; Careful with that BBB.
Read More

BioWorld MedTech’s Neurology Extra for Feb. 5, 2021

Feb. 5, 2021
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Smartwatch sensors enable remote monitoring, treatment guidance for Parkinson’s patients; Imaging of a living brain can help differentiate dementia; Morphine itch comes from neurons, not mast cells.
Read More

BioWorld MedTech’s Neurology Extra for Jan. 29, 2021

Jan. 29, 2021
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Genetic analysis of symptoms yields new insights into PTSD; AI used to predict schizophrenia in relatives of patients; Growth factors linked to lysosomes, Parkinson’s risk; Study links ALS gene to tumor suppressor, transcription changes.
Read More

BioWorld MedTech’s Neurology Extra for Jan. 22, 2021

Jan. 22, 2021
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: Personalized neuromodulation technique developed for obsessive-compulsive behavior; Improving pain research with new sensory neuron model; Tau end run prevents memory deficits, but not inflammation; Presenilin mutations affect neuronal stem cells.
Read More

BioWorld MedTech’s Neurology Extra for Jan. 15, 2021

Jan. 15, 2021
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Intranasal antipsychotic delivery method promises relief from adverse side effects; Increased risk of Parkinson’s disease in patients with schizophrenia; Elusive link between seizures, cell signaling protein identified.
Read More

BioWorld MedTech’s Neurology Extra for Jan. 8, 2021

Jan. 8, 2021
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Focused ultrasound shows promise for Parkinson’s disease; Blood test developed for Alzheimer’s prognosis in symptom-free patients; Bedside EEG test predicts recovery in unresponsive brain injury patients.
Read More

BioWorld MedTech’s Neurology Extra for Dec. 18, 2020

Dec. 18, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Research suggests SARS-CoV-2 enters the brain; Technique developed to predict seizures; Machine intelligence improves brain mapping research; Hearing, blood sugar linked to cognitive function among older Latinos.
Read More

BioWorld MedTech’s Neurology Extra for Dec. 11, 2020

Dec. 11, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: Genetic differences important in Alzheimer’s diagnosis; Stanford develops tool for studying neural activity; Gut microbiota plays a role in brain function, mood regulation.
Read More

BioWorld MedTech’s Neurology Extra for Dec. 4, 2020

Dec. 4, 2020
By Andrea Applegate
Keeping you up to date on recent developments in neurology, including: AI developed to predict psychiatric diagnoses from Facebook activity; AIR coil from GE Healthcare shows promise for whole-brain imaging; Big data analysis suggests role of brain connectivity in epilepsy-related atrophy; Gestational age linked to ADHD in children with Down syndrome.
Read More
View All Articles by Andrea Applegate

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 14, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for May 14, 2025.
  • Koreabio Humanase KOH Sungho

    FDA shift from animal testing fuels organoid, organ-on-chip demand

    BioWorld Science
    The U.S. FDA’s decision to phase out animal testing for INDs is driving a new market of alternative, nonanimal testing technologies like organoids and...
  • AI generated, 3D rendering of protein degradation

    AACR 2025: Induced proximity strategy, beyond degraders

    BioWorld
    Targeted protein degradation has yet to notch its first approval. But with more than two dozen agents now in clinical trials, the strategy’s ultimate clinical...
  • Businessman and IPO virtual screen

    Three med-tech IPOs on the horizon

    BioWorld MedTech
    April may not have brought rain to med-tech, but tariffs and financial uncertainty certainly dampened the enthusiasm for IPOs. With those clouds lifting, three...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe